Paul Drayson plans raising $78M via new AI drug research firm's IPO

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Paul Drayson, Britain's biotech entrepreneur, is eager to attract $78M through a new AI drug research company's initial public offering, planning to list on the London AIM market the following week.
Back to articles

Actual Topics

Tue, 07 Aug 2018 09:57:08 GMT

German industrial production misses market estimates in June

The German Federal Statistical Office reported on Tuesday that the industrial production in Germany fell 0.9% in June, compared to a 2.4% increase in May.

Tue, 07 Aug 2018 09:35:24 GMT

AnaCap acquires Slovenia's bank Nova KBM first loan portfolio

The specialist EU financial services private equity group AnaCap Financial Partners acquired on Monday the first loan portfolio and lien corporate debt from the Slovenian second largest bank Nova KBM.

Subscribe to "Fundamental Analysis" feed

Subscribe
Pre viac informácií o Dukascopy Bank CFD / Forex obchodných platformách a ostatných záležitostiach
nás prosím kontaktujte alebo požiadajte o hovor od nás.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Pre viac informácií o Dukascopy Bank CFD / Forex obchodných platformách a ostatných záležitostiach
nás prosím kontaktujte alebo požiadajte o hovor od nás.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.